Table Info

Characteristics	DKA	DKALK
Diabetes (RBS > 14 mmol/L)	Present	Present
Serum and urine ketones	Present (> 3 mEq/L)	Present (> 3 mEq/L)
Anion gap	> 18 mEq/L	> 18 mEq/L
Arterial pH	< 7.3	> 7.4
Bicarbonate	< 18 mEq/L	> 18 mEq/L

Declarations

Author contributions

PA: Conceptualization, Writing—original draft, Writing—review & editing, Validation. NM, SB, EO, AE, EE, AOE, ASA, CBO, and PNO: Writing—original draft, Writing—review & editing. All authors gave approval to the final submission.

Conflicts of interest

The authors declare no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Bleicher S. Ketosis not always acidosis: “heartburn” can be relevant. Diabetic Outlook. 1967;2:3–4.

Cao S, Cao S. Diabetic Ketoalkalosis: A Common Yet Easily Overlooked Alkalemic Variant of Diabetic Ketoacidosis Associated with Mixed Acid-Base Disorders. J Emerg Med. 2023;64:282–8. [DOI] [PubMed]

Watanabe Y, Noda K, Akazawa K, Fukuyama J. Two cases of type 1 diabetic women with diabetic ketoacidosis presenting as alkalaemia. Diabetes Res Clin Pract. 2009;83:e54–7. [DOI] [PubMed]

Kamel KS, Halperin ML. Acid-base problems in diabetic ketoacidosis. N Engl J Med. 2015;372:546–54. [DOI] [PubMed]

Elisaf MS, Tsatsoulis AA, Katopodis KP, Siamopoulos KC. Acid-base and electrolyte disturbances in patients with diabetic ketoacidosis. Diabetes Res Clin Pract. 1996;34:23–7. [DOI] [PubMed]

Nanavati S, Kumar V, Melki G, Singhal M. Diabetic ketoalkalosis: misnomer or undiagnosed variant of diabetic ketoacidosis. BMJ Case Rep. 2018;2018:bcr2018226092. [DOI] [PubMed] [PMC]

Svart MV, Voss TS, Bayat M, Madsen LR, Andersen LT, Poulsen PL, et al. Rare presentations of ketoacidosis: diabetic ketoalkalosis and ketoacidosis secondary to fasting and muscular dystrophy. Clin Diabetes. 2015;33:37–9. [DOI] [PubMed] [PMC]

Dashora U, Patel DC, Gregory R, Winocour P, Dhatariya K, Rowles S, et al. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium–glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020). Diabet Med. 2021;38:e14458. [DOI] [PubMed]

Huggins EA, Chillag SA, Rizvi AA, Moran RR, Durkin MW. Diabetic ketoalkalosis in children and adults. South Med J. 2014;107:6–10. [DOI] [PubMed]

10.

Rastegar A. Use of the ∆AG/∆HCO^3- ratio in the diagnosis of mixed acid-base disorders. J Am Soc Nephrol. 2007;18:2429–31. [DOI] [PubMed]

11.

Lim KC, Walsh CH. Diabetic ketoalkalosis: a readily misdiagnosed entity. Br Med J. 1976;2:19. [DOI] [PubMed] [PMC]

12.

Koett J, Howell J, Steinberg S, Wolf P. Diabetic ketoalkalosis. Clin Chem. 1979;25:1329–30. [PubMed]

13.

Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335–43. [DOI] [PubMed] [PMC]

14.

Jaramillo J, Joseph M, Aldubayan M, Sinert R. New Test, Old Disease: A Case Series of Diabetic Ketoalkalosis. J Emerg Med. 2020;58:e9–16. [DOI] [PubMed]

15.

Kumar V, Nanavati SM, Komal F, Ortiz LC, Paul N, Kumar M, et al. Ketoalkalosis: Masked presentation of diabetic ketoacidosis with literature review. J Endocrinol Metab. 2018;7:194–6. [DOI]

16.

Brill A, Chheda N, Strama D, Soundararajan R. Diabetic Ketoalkalosis: A Case Report. Clin Pract Cases Emerg Med. 2024;8:111–4. [DOI] [PubMed] [PMC]

17.

Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol. 2003;2:95–108. [DOI] [PubMed]

18.

Kearney T, Dang C. Diabetic and endocrine emergencies. Postgrad Med J. 2007;83:79–86. [DOI] [PubMed] [PMC]

19.

Pasquel FJ, Tsegka K, Wang H, Cardona S, Galindo RJ, Fayfman M, et al. Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study. Diabetes Care. 2020;43:349–57. [DOI] [PubMed] [PMC]

20.

Savage MW, Dhatariya KK, Kilvert A, Rayman G, Rees JAE, Courtney CH, et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011;28:508–15. [DOI] [PubMed]

21.

Goyal N, Miller JB, Sankey SS, Mossallam U. Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. J Emerg Med. 2010;38:422–7. [DOI] [PubMed]

22.

Barski L, Nevzorov R, Rabaev E, Jotkowitz A, Harman-Boehm I, Zektser M, et al. Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care. Isr Med Assoc J. 2012;14:299–303. [PubMed]

23.

Glaser NS, Wootton-Gorges SL, Buonocore MH, Marcin JP, Rewers A, Strain J, et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes. 2006;7:75–80. [DOI] [PubMed]

24.

Joint British Diabetes Societies for Inpatient Care [Internet]. The British Diabetic Association; [cited 2024 May 21]. Available from: https://www.diabetes.org.uk/for-professionals/improving-care/good-practice/inpatient-and-hospital-care/joint-british-diabetes-society-for-inpatient-care/

25.

Goguen J, Gilbert J; Diabetes Canada Clinical Practice Guidelines Expert Committee. Hyperglycemic Emergencies in Adults. Can J Diabetes. 2018;42 Suppl 1:S109–14. [DOI] [PubMed]

26.

Eledrisi MS, Elzouki A. Management of Diabetic Ketoacidosis in Adults: A Narrative Review. Saudi J Med Med Sci. 2020;8:165–73. [DOI] [PubMed] [PMC]

27.

Jerrard D, Hanna J. Diabetic ketoacidosis with alkalemia. Am J Emerg Med. 2001;19:521–2. [DOI] [PubMed]

28.

Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19 Suppl 27:155–77. [DOI] [PubMed]

29.

Gamba G, Oseguera J, Castrejón M, Gómez-Pérez FJ. Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial. Rev Invest Clin. 1991;43:234–8. [PubMed]

30.

Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016;2016:CD011281. [DOI] [PubMed] [PMC]